K

Klinik Favoriten | Infectious and Tropical Medicine

Research site

(Unclaimed)

Location

Kundratstrasse 3, Vienna, Vienna, Austria

Site insights

Top conditions

Top treatments

NTR-441

Ziltivekimab

Semaglutide

Atezolizumab

Bevacizumab

Pamrevlumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 7 total trials

A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation (HERMES)

This study will be done to see if ziltivekimab can be used to treat people living with heart failure and inflammation. Participants will either get z...

Enrolling

Heart Failure

Drug: Placebo

Drug: Ziltivekimab

A Study of Atezolizumab With Lenvatinib or Sorafenib Versus Lenvatinib or Sorafenib Alone in Hepatocellular Carcinoma Previously Treated With Atezolizumab and Bevacizumab (IMbrave251)

This is a Phase III, open-label, multicenter, randomized, two-arm study designed to evaluate the efficacy and safety of atezolizumab plus either lenv...

Active, not recruiting

Unresectable Hepatocellular Carcinoma

Drug: Lenvatinib

Drug: Atezolizumab